Agenda

Saturday June 28, 2025

• 8:00 AM – 8:05 AM

  Welcome

• 8:05 AM – 8:50 AM

  Debate: Will Cell-Free DNA Technology Improve Overall Survival for Patients with Diffuse Large B-Cell Lymphoma? Yes vs No

• 8:05 AM – 8:25 AM

  Yes, Cell-Free DNA Technology Will Improve Overall Survival for Patients with Diffuse Large B-Cell Lymphoma

  • Invited Debate Speaker
    • David Russler-Germain
• 8:25 AM – 8:45 AM

  No, Cell-Free DNA Technology Will Not Improve Overall Survival for Patients with Diffuse Large B-Cell Lymphoma

  • • Sven De VosMD, PhD
• 8:45 AM – 8:50 AM

  Q&A

  • • Sven De VosMD, PhD
  • Invited Panelist
    • David Russler-Germain
• 8:50 AM – 8:55 AM

  Break

• 8:55 AM – 9:55 AM

  Non-Accredited Sponsored Session

• 9:55 AM – 10:25 AM

  Selected Topics in Lymphoma

• 10:25 AM – 10:55 AM

  Exhibit Hall Break

• 10:55 AM – 11:40 AM

  Debate: When Should BTK Inhibitors Be Used to Treat Mantle Cell Lymphoma? Upfront vs Second-Line